Home / Industry News / 2010 / Bristol-Myers Squibb to Freeze Salaries in 2010

Bristol-Myers Squibb to Freeze Salaries in 2010

Source: PharmaManufacturing.com

Feb 04, 2010

WSJ.com

Print Email

Show More Content

More News:

Roche wins key lung cancer combo approval

12/07/2018

Roche Holding’s Tecentriq immunotherapy, in combination with Avastin and chemotherapy, won U.S. FDA approval as a first-line treatment for a type of lung cancer.
Anti-pharma couple found dead

12/07/2018

An elderly Pennsylvania couple, know for their personal crusade against McNeil Consumer Healthcare, was found dead outside their home.
Tris Pharma recalls infant ibuprofen

12/06/2018

Tris Pharma has voluntarily recalled three lots of Infants' Ibuprofen Concentrated Oral Suspension because the products have been found to potentially have higher concentrations of ibuprofen.
Bayer stops trial of drug it hopes will be a blockbuster

12/05/2018

Bayer has halted testing for vilaprisan, a new medication developed to treat uterine fibroids. The company said that it’s concerned about the risk of side effects uncovered in toxicology data.
FDA gives Roche immunotherapy drug priority review

12/05/2018

The FDA has awarded Roche an accelerated review of its immunotherapy drug, Tecentriq, to treat non small-cell lung cancer.
FDA fast tracks Amgen myeloma treatment

12/04/2018

The drugmaker's trial of its bispecific antibody for multiple myeloma found that seven out of ten patients given the second-highest dose of AMG420 responded to the drug
Mylan recalls all batches of blood pressure drug in U.S.

12/04/2018

The company recalled some batches two weeks ago but is now recalling 104 additional lots.
Unilever nabs GSK nutrition business

12/03/2018

After beating out potential bids from Nestle and Coca-Cola, Unilever has signed a deal to buy GlaxoSmithKline’s nutrition business, Horlicks, for $3.8 billion.
Janssen affiliate and Dutch company ink $1.6B deal to develop cancer drug

12/03/2018

Cilag, an affiliate of Janssen, is teaming up with a Netherlands-based biopharmac company called Argenx to develop a treatment for certain cancers.
GSK bets big with Tesaro buy

12/03/2018

GlaxoSmithKline has agreed to buy cancer biotech, Tesaro, for $5.1B.

Pharma Manufacturing

Join the discussion

Comments

FDA declines to approve new oral film ED drug

The FDA has declined to approve an oral film male enhancement drug…

Merck KGaA, Pfizer drug fails late-stage cancer trial

Novartis bets on cutting-edge treatments

Novartis has spent nearly $15 billion in the past year to step up its…

U.S. court allows Dr. Reddy's to sell Indivior copycat

The U.S. Court of Appeals for the Federal Circuit lifted a preliminary…

Cambrex to acquire Avista for $250 million

The acquisition will add early stage API and finished dosage form…

FDA slaps Akorn plant with Form 483

The regulatory body found issues at the drugmaker's New Jersey site,…

Two former drug executives headed to prison

Former executives from Valeant Pharmaceuticals International and Philidor…

Novartis scraps U.S. filing for biosimilar rituximab

Novartis International AG’s Sandoz division will abandon its quest to…

FDA approves controversial potent opioid

The U.S. FDA has approved AcelRx Pharmaceuticals’ Dsuvia sublingual…

Pfizer loses major patent battle in the U.K.

Lyrica has officially fallen off the patent cliff in Britain.

Top 10 Selling Drugs in 2024

Which drugs will reign supreme in six years? It’s not too soon to roll…

Puerto Rico Pharma: Battered but Unbroken

One year after Hurricane Maria, Puerto Rico's pharma industry is standing…

Mylan plant hit with FDA Form 483 for cleaning practices

A West Virginia plant owned by Mylan Pharmaceuticals has been issued a…

Shrinking Big Pharma

Why building smaller manufacturing plants is the next big thing

2018 Pharma Innovation Awards

A much-deserved celebration of manufacturing technologies, hand-picked by…

Weighing and Dispensing: Do it Right

The weighroom is the entry point to manufacturing and a transition point…

CAPA and Root Cause Analysis

Recent FDA Warning Letters have cited insufficient corrective and…

Annual Product Reviews: How to Conduct an Effective Annual Product Quality Review

More than just a regulatory requirement, an APR helps the manufacturer to…

USP Updates <61> and <62> for Microbial Testing of Non-Steriles

Significant changes include more clarity on enumberation and specified…

Serialization and the Drug Quality & Security Act

The supply chain for genuine pharmaceuticals has grown longer, and every…